BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14972417)

  • 1. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
    Billinger M; Hess OM; Meier B
    Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function.
    Schultz MJ
    Radiology; 2007 Dec; 245(3):918-9; author reply 918-9. PubMed ID: 18024462
    [No Abstract]   [Full Text] [Related]  

  • 5. The third strike.
    Brinker JA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):284-5. PubMed ID: 12410498
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
    Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
    J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast agent nephropathy.
    Nicol P; Axelson C
    Eur Heart J; 2004 Aug; 25(15):1369; discussion 1369-70. PubMed ID: 15288173
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?
    Ma IW; Hladunewich M
    CMAJ; 2004 Apr; 170(8):1231. PubMed ID: 15078844
    [No Abstract]   [Full Text] [Related]  

  • 9. In search of an algorithm to prevent acute kidney injury.
    Dauerman HL
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA; Jensen LA; Ferguson IA; Williams RG
    Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
    Bouzas-Mosquera A; Recio-Mayoral A
    Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455
    [No Abstract]   [Full Text] [Related]  

  • 12. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Fishbane S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
    Stenstrom DA; Muldoon LL; Armijo-Medina H; Watnick S; Doolittle ND; Kaufman JA; Peterson DR; Bubalo J; Neuwelt EA
    J Vasc Interv Radiol; 2008 Mar; 19(3):309-18. PubMed ID: 18295688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast-induced nephropathy].
    Westenfeld R; Rump LC
    Dtsch Med Wochenschr; 2013 Apr; 138(14):715-8. PubMed ID: 23533037
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of contrast-induced nephropathy and current use of N-acetylcysteine (NAC).
    Anwar M; Ledger S
    CANNT J; 2005; 15(1):33-8,quiz 38-9. PubMed ID: 15909775
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
    Safirstein R; Andrade L; Vieira JM
    N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
    [No Abstract]   [Full Text] [Related]  

  • 17. N-acetylcysteine somewhere between Scylla and Charybdis.
    Sochman J
    J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
    [No Abstract]   [Full Text] [Related]  

  • 18. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
    Rizzato G
    Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylcysteine for radiocontrast nephropathy.
    Tepel M; Zidek W
    Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
    Bouzas-Mosquera A; Vázquez-Rodríguez JM
    Am J Cardiol; 2008 Mar; 101(6):910. PubMed ID: 18328863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.